
China · Pharmaceuticals startup
HealSun Biopharm is a biotechnology company based in Hangzhou, China, founded in 2015.
Funding reportedLast round: Series B
HealSun Biopharm is a biotechnology company based in Hangzhou, China, founded in 2015.
The company specializes in providing comprehensive R&D and production solutions for antibodies, fusion proteins, and ADC/XDC products. Their core services encompass protein engineering, early druggability evaluation, stable cell line construction, and process development for antibodies and ADCs. They also offer CMC development, pilot-scale production, IND declaration support, clinical sample manufacturing, and commercial GMP production. HealSun's platform capabilities include molecular design, protein activity analysis, conjugation services, analytical development, and lyophilization preparation. HealSun Biopharm primarily serves global biopharmaceutical and biotechnology companies, offering preclinical and process development support, as well as services for antibody, recombinant protein, and conjugate-drug development.
Funding, as reported
What they build
Known for
health carebiologics clinical supplybiologics process validationcustom cell line engineeringadc conjugation platformbiologics developmentmanufacturingbiologics process developmentbiologics r&dgmp manufacturingbiologics process transferbiologics process optimizationmrna cro servicesbiologics analytical testingfut8 knockout platformstable cell line platform
Built with from their website
Viewport MetaVideoJSMobile FriendlyjQuerySwiperApple iOSICPHTTP/3HSTSNginx
Add your raise, your deck and your story, and put HealSun Biopharm in front of investors. Or tell us what we have wrong.